Recent Updates
Recently added Catalysts
PRE Positive Sentiment

Prenetics Announces Participation in December Investor Conferences

Key Takeaway: Prenetics Global Limited, a health sciences company, announced its participation in two investor conferences scheduled for December 2024. The CEO, Danny Yeung, will present at the iAccess Alpha Virtual Best Ideas Winter Conference on December 10, followed by one-on-one meetings on December 11. At the 13th Annual ROTH Deer Valley Event, President David Vanderveen will also conduct one-on-one investor meetings. The company emphasizes its commitment to advancing consumer and clinical health through innovative services and technology.
Price reaction · baseline $4.3 (2024-12-03 close) · hit after-hours · 2 other PRE headline(s) in the window, move may be shared
day 0 close
+2.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Prenetics is actively engaging with investors through key conferences.
  • The management team includes experienced members, enhancing credibility.
  • The company is focused on innovative health solutions and technologies.

Full Press Release Details

CHARLOTTE, N.C., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited, (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announced that members of the Prenetics management team will participate in two upcoming investor conferences.
iAccess Alpha Virtual Best Ideas Winter Conference 2024
Date: December 10-11, 2024
Presentation: December 10, 2024 at 10:00am ET
Danny Yeung, Chief Executive Officer, will deliver a presentation on December 10, 2024, and will be joined by Stephen Lo, Chief Financial Officer, and David Vanderveen, President of Prenetics Americas, for one-on-one investor meetings to be held on December 11, 2024.
13th Annual ROTH Deer Valley Event
Date: December 11-13, 2024
Location: Park City, UT
David Vanderveen, President of Prenetics Americas, will be hosting one-on-one investor meetings throughout the conference.
Mr. Vanderveen has had a successful 30-year track record in beverage, nutrition, and technology, leading disruptive change at both Nirvana Water Sciences and XS Worldwide as prior CEO.
For more information or to schedule a meeting with management, please contact the Company’s investor relations at PRE@mzgroup.us.
Prenetics (NASDAQ:PRE), a leading health sciences company, is dedicated to advancing consumer and clinical health. Our consumer initiative is led by IM8, a new health and wellness brand and Europa, one of the largest sports distribution companies in the USA. Our clinical division is led by Insighta, our $200 million venture focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for comprehensive genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer comprehensive DNA tests. Each of Prenetics’ units synergistically enhances our global impact on health, embodying our commitment to ‘enhancing life through science’. To learn more about Prenetics, please visit www.prenetics.com.
Investor Relations Contact:
Investor Relations / Corporate Finance
Prenetics Global Limited

Frequently Asked Questions

What events will Prenetics participate in?

Prenetics will participate in the iAccess Alpha Virtual Conference and the 13th Annual ROTH Deer Valley Event.

When is Prenetics' presentation at the iAccess Alpha Conference?

Prenetics' presentation at the iAccess Alpha Conference is scheduled for December 10, 2024, at 10:00am ET.

Who will represent Prenetics at the conferences?

Danny Yeung, Stephen Lo, and David Vanderveen will represent Prenetics during the conferences.

What is Prenetics dedicated to?

Prenetics is dedicated to advancing consumer and clinical health through innovative initiatives.

How can one schedule a meeting with Prenetics' management?

Meetings can be scheduled by contacting Prenetics' investor relations at PRE@mzgroup.us.

Last updated: Dec 4, 2024